ILK and neoplasm: For instance, tumor progression by targeting surviving mRNA [21,26] and down-regulating Integrin-Linked Kinase (ILK) [35]; up-regulating p53 by weakening the stability of MDM2 [22]; regulating steoblast cell proliferation and differentiation by decreasing BMP7.